MRD / Regn No. : 454 Date : 01/06/2026
Patient Name : Rita Upadhyay Age & Gender : 52 Yrs. / Female
Contact No. : 9836669178 UHID :
Ht / Wt / BMI : 156 / 99 / 40.68 BP S / BP D : 139 / 78
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (12/Sep/2018) | OBESITY (12/Sep/2022) |
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 211 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 8.8 % | LDL LOW DENSITY LIPOPROTEIN: 102 mg/dL | MICROALBUMIN CREATININE RATIO: 13.3 mcg/mg | POST PRANDIAL GLUCOSE (2HPP): 189 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 ATORVASTATIN 20 MG
ATORVA 20 MG 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
TAKE AT NIGHT. MAY CAUSE MUSCLE PAIN AND FATIGUE
2 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
UDAPA 10 MG 		PO 1-0-0
TILL NEXT VISIT
3 ANTIHYPERGLYCEMIC GLIMIPERIDE 2 MG + METFORMIN 500 MG
GEMER 2 MG 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
4 INJECTION SEMAGLUTIDE 0.25 MG
NOVELTREAT 0.25 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 01/Oct/2026
Tests Suggested For Next Visit : CHECK FASTING & PP SUGARS AFTER 4 WEEKS AND INFORM,HBA1C-HPLC METHOD,UACR: SPOT SAMPLE,LFT WITH PLATELET COUNT
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: